In melanoma TME, IDO1 and TDO pathways are hyper-activated in both melanoma cells and tumor-infiltrating lymphocytes by immune cell-derived IFN-γ, which reduces tryptophan in TME. The gene discussed is TDO2; the disease is melanoma.